Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
MAILBOX | CHINESE | ENGLISH
About Us
Overview
Our Culture
Chairman Message
Company Organization
Management Team
Honor & Qualification
Company View
Our History
Contact Us
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621
Fax: +86-531-88817925
Zip Code: 250101
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com
Our History Now Position:Home > About Us > Our History

December, 2010: The Company was restructured to become a “5150 Enterprise", and obtained financial support by Jinan Municipal Government.

September, 2011: For the first time, the research project entitled “Development of novel anticancer hypoxia-activated prodrugs to treat hepatocellular carcinoma” was included in the Annual Science and Technology Development Plan and obtained financial support by Department of Science and Technology in Shandong Province (Project No. 2011GGD01004).

November, 2011: A delegation for inspecting Qilu SAR Personnel by Shandong Provincial government visited our company, which was the only selected new drug R&D enterprise.

February, 2012: The first invention patent application entitled “Synthesis of anticancer molecular targeted drug Crizotinib” was submitted to State Intellectual Property Office of China.

February, 2012:  Chairman was awarded “Taishan Scholar Oversea Distinguished Expert” by the Shandong Provincial government.

March, 2012: The Company was awarded the honorary title “High-Level Personnel Entrepreneurial Advanced Unit” by Jinan High-Tech Development Zone.

July, 2012: For the first time, the research project entitled “Optimization of synthesis route of Crizotinib and the development of novel hypoxia-activated prodrugs” was included in the Annual Science and Technology Development Plan and obtained financial support by Jinan Municipal Government (Project No. 201201039).

November, 2012: Chairman was awarded “Entrepreneurship Award for Returning Oversea Scholar” by Shandong Provincial government.

November, 2012: For the first time, the research project (No. 2011GGD01004) entitled “Development of novel anticancer hypoxia-activated prodrugs to treat hepatocellular carcinoma” was completed, and passed the acceptance by Department of Science and Technology in Shandong Province.

January, 2013: For the first time, the research project entitled "Development of new hypoxia-activated prodrugs based on Camptothecin” was included the high-level personnel tracking support plan by Jinan Municipal Government, and obtained financial support (Project No. 201219005).






Close
QQ1: 1762738062
QQ2: 1919147143
MSN: sales-trio
SKYPE: janisa.yan